78 related articles for article (PubMed ID: 23539050)
1. Is a legacy effect possible in IgA nephropathy?
Coppo R
Nephrol Dial Transplant; 2013 Jul; 28(7):1657-62. PubMed ID: 23539050
[TBL] [Abstract][Full Text] [Related]
2. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.
Maeda I; Hayashi T; Sato KK; Shibata MO; Hamada M; Kishida M; Kitabayashi C; Morikawa T; Okada N; Okumura M; Konishi M; Konishi Y; Endo G; Imanishi M
Nephrol Dial Transplant; 2012 Jul; 27(7):2806-13. PubMed ID: 22492824
[TBL] [Abstract][Full Text] [Related]
3. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
4. Immune modulating therapy for IgA nephropathy: rationale and evidence.
Floege J; Eitner F
Semin Nephrol; 2008 Jan; 28(1):38-47. PubMed ID: 18222345
[TBL] [Abstract][Full Text] [Related]
5. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
6. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy.
Hotta O; Miyazaki M; Furuta T; Tomioka S; Chiba S; Horigome I; Abe K; Taguma Y
Am J Kidney Dis; 2001 Oct; 38(4):736-43. PubMed ID: 11576876
[TBL] [Abstract][Full Text] [Related]
7. Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients.
Ohya M; Otani H; Minami Y; Yamanaka S; Mima T; Negi S; Yukawa S; Shigematsu T
Clin Nephrol; 2013 Jul; 80(1):47-52. PubMed ID: 23557791
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Pani A; Fogazzi G; Altieri P; Ponticelli C
J Nephrol; 1999; 12(5):308-11. PubMed ID: 10630693
[TBL] [Abstract][Full Text] [Related]
9. Tonsillectomy does not prevent a progressive course in IgA nephropathy.
Rasche FM; Schwarz A; Keller F
Clin Nephrol; 1999 Mar; 51(3):147-52. PubMed ID: 10099887
[TBL] [Abstract][Full Text] [Related]
10. Regression of IgA nephropathy: a repeat biopsy study.
Hotta O; Furuta T; Chiba S; Tomioka S; Taguma Y
Am J Kidney Dis; 2002 Mar; 39(3):493-502. PubMed ID: 11877568
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of tonsillectomy with modified high-dose intravenous methylprednisolone therapy in patients with IgA nephropathy].
Sugawara K; Takeda K; Nakai K; Takahashi N; Adachi T; Fukuda T; Miura S
Nihon Jinzo Gakkai Shi; 2008; 50(8):1017-23. PubMed ID: 19172803
[TBL] [Abstract][Full Text] [Related]
12. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
13. [Management of IgA nephropathy].
Amoroso L; De Sanctis L; Cappelli P; Di Vito R; Sirolli V; Bonomini M
G Ital Nefrol; 2011; 28(6):622-32. PubMed ID: 22167613
[TBL] [Abstract][Full Text] [Related]
14. Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.
Cruzado JM; Poveda R; Ibernón M; Díaz M; Fulladosa X; Carrera M; Torras J; Bestard O; Navarro I; Ballarín J; Romero R; Grinyó JM
Nephrol Dial Transplant; 2011 Nov; 26(11):3596-602. PubMed ID: 21393611
[TBL] [Abstract][Full Text] [Related]
15. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
16. [Long-term administration of cyclosporine A in patients with IgA nephropathy].
Chábová V; Tesar V; Zabka J; Rychlík I; Merta M; Jirsa M; Stejskalová A; Stejskal J
Cas Lek Cesk; 1996 Dec; 135(24):803-6. PubMed ID: 9072300
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
Ferrari P; Frey FJ
Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
[TBL] [Abstract][Full Text] [Related]
18. The treatment of IgA nephropathy: status at the end of the millenium.
Glassock RJ
J Nephrol; 1999; 12(5):288-96. PubMed ID: 10630691
[TBL] [Abstract][Full Text] [Related]
19. Treatment of progressive IgA nephropathy: an update.
Wang W; Chen N
Contrib Nephrol; 2013; 181():75-83. PubMed ID: 23689569
[TBL] [Abstract][Full Text] [Related]
20. [Advances in primary glomerular disease in 2007].
Ara J
Nefrologia; 2008; 28 Suppl 5():85-9. PubMed ID: 18847426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]